课题基金 / 基金详情

NEW BIOMEDICAL INTERFACE MATERIALS

NEW BIOMEDICAL INTERFACE MATERIALS
新型生物医学界面材料
批准号:
2028365
负责人:
ROGER E MARCHANT
金额:
$22.2万
依托单位国家:
美国
项目类别:
财政年份:
1988
资助国家:
美国
项目状态:
已结题
起止时间:
1988-03-01 至 1998-11-30

项目摘要

项目成果

ROGER E MARCHANT的其他基金

相关文献

中文摘要
翻译
用于心血管假体的生物材料受到众所周知的 与表面引起的血栓形成和感染相关的问题。 这些界面问题是一直存在的主要问题 悬而未决并限制了现有的成功和适用性 生物医学聚合物。 拟议的研究将继续侧重于编制新的 生物医学界面材料,通过新的表面改性 方法,旨在改善宿主对现有 生物材料植入物。具体地说,将使用界面材料 探讨熵排斥力(ERF)的作用 关于血液相容性。将要检验的假设是,ERF 表示吸附的主要决定因素,而 吸附等离子体的组成、组织和功能状态 蛋白质,然后决定随后的细胞和分子表面 互动。我们建议对临床相关的假设进行检验。 生物材料和对照,表面用一系列界面修饰 材料的范围从疏水性到亲水性,随着 通过射频等离子体聚合制备的水合度, 到用于最大化ERF的高度溶剂化低聚糖, 新型寡糖-碳氢-低聚糖(OHO)的制备 三嵌段生物聚合物将通过坚固的结合到测试表面 疏水相互作用。每一次表面改性都将表征 通过光谱和物理方法,包括原子力 显微镜(AFM)将允许在亚分子水平上进行成像 以及分子间作用力的检验。该系统的稳定性 将界面材料暴露在水、缓冲液中后进行测定 和动态流动条件下的十二烷基硫酸钠溶液。的影响 血浆蛋白和血小板表面的界面性质与ERF 相互作用将在体外通过测定在静态条件下进行 和动态流动条件,(L)的量、成分和 吸附的关键血浆蛋白的功能完整性 蛋白质~溶液,黏附蛋白耗尽的介质,以及人类 血浆.使用放射性标记法、红外光谱分析和免疫标记法 利用单抗黏附蛋白质的技术和亚分子原子力显微镜 蛋白质的成像;以及(2)蛋白质的数量和功能状态 吸附的血小板。 从这些研究中,我们将尝试通过以下方式确定其机制 界面性质和电流变液的哪一种变化会影响 黏附蛋白的吸附和功能状态,以及这是如何 与血液相容性有关。拟议的研究,如果 成功,将导致重要的新班级的发展 对蛋白质具有抵抗力的生物医学界面材料 吸附。
英文摘要
Biomaterials used in cardiovascular prostheses suffer from well-known problems associated with surface-induced thrombosis and infection. These interfacial problems are major concerns that have remained unresolved and limited the success and applicability of existing biomedical polymers. The proposed studies will continue to focus on the preparation of new biomedical interface materials, through novel surface modification methodologies, designed to improve the host response to existing biomaterial implants. Specifically, interface materials will be used to investigate of the role of entropic repulsive hydration forces (ERF) on blood compatibility. The hypothesis that will be tested is that ERF represents a major determining factor in the adsorption, and the composition, organization and functional state of adsorbed plasma proteins, which then determines subsequent cell and molecular surface interactions. We propose to test the hypothesis on clinically-relevant biomaterials and controls, surface-modified with a series of interface materials that range from hydrophobic, to hydrophilic with increasing degree of hydration, prepared by radiofrequency plasma polymerization, to highly solvated oligosaccharides that will used to maximize ERF, prepared from novel oligosaccharide-hydrocarbon-oligosaccharide (OHO) triblock biopolymers that will be bound to test surfaces by strong hydrophobic interaction. Each surface modification will characterized by spectroscopic and physical methods, including atomic force microscopy (AFM) which will permit imaging at the submolecular level and examination of the intermolecular forces. The stability of the interface materials will be determined after exposure to water, buffer and SDS solution, under dynamic flow conditions. The effect of interfacial properties and ERF on plasma protein and platelet-surface interactions will be investigated in vitro by determining, under static and dynamic flow conditions, (l) the amount, composition, and functional integrity of key plasma proteins adsorbed from protein~solutions, media depleted of adhesive proteins, and human plasma; using radiolabel methods, infrared spectroscopy, immunolabel techniques employing Mab to adhesive proteins, and by submolecular AFM imaging of proteins; and (2) the amount and functional state of adsorbed platelets. From these studies, we shall attempt to determine the mechanism by which alteration in interfacial properties and ERF affects the adsorption and functional state of adhesive proteins, and how this correlates to blood compatibility. The proposed research, if successful, will lead to the development of important new classes of biomedical interface materials, that exhibit resistance to protein adsorption.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Vascularization of polymeric tissue beds
  • 批准号:
    7828505
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2009
  • 负责人:
    ROGER E MARCHANT
  • 依托单位:
Vascularization of polymeric tissue beds
  • 批准号:
    7935299
  • 项目类别:
  • 资助金额:
    $50.0万
  • 财政年份:
    2009
  • 负责人:
    ROGER E MARCHANT
  • 依托单位:
Biomimetic Engineering of Vascular Prostheses
  • 批准号:
    7575728
  • 项目类别:
  • 资助金额:
    $44.91万
  • 财政年份:
    2008
  • 负责人:
    ROGER E MARCHANT
  • 依托单位:
Biomimetic Engineering of Vascular Prostheses
  • 批准号:
    7372150
  • 项目类别:
  • 资助金额:
    $39.26万
  • 财政年份:
    2008
  • 负责人:
    ROGER E MARCHANT
  • 依托单位: